Maria Leandro: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "|first7=" to " | first7 = ")
(fix link)
 
(38 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{stub}}
{{stub}}
{{NeedsImage}}
{{NeedsImage}}
'''Maria Leandro''', MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, [[United Kingdom]]. Her research interests are in inflammatory arthritis, rheumatoid arthritis, [[B cell]] directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.<ref>{{Cite web|url=https://www.uclh.nhs.uk/OurServices/Consultants/Pages/DrMariaLeandro.aspx|title=Dr Maria Leandro - UCL Hospitals|last=|first=|date=|website=|archive-url=|archive-date=|url-status=|access-date=}}</ref>
'''Maria Leandro''', MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, [[United Kingdom]]. Her research interests are in inflammatory arthritis, rheumatoid arthritis, [[B cell]] directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.<ref>{{Cite web|url=hhttps://www.uclh.nhs.uk/our-services/find-consultant/dr-maria-leandro | title = Dr Maria Leandro - UCL Hospitals|last = | first = | date = |website=|archive-url=|archive-date=|url-status=|access-date=}}</ref>


== Notable studies ==
== Notable studies ==
*2016, Extended [[B cell]] phenotype in patients with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]: A cross-sectional study<ref name="Mensah, 2016" />  [https://onlinelibrary.wiley.com/doi/full/10.1111/cei.12749 (Full Text)]
*2016, Extended [[B cell]] phenotype in patients with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]: A cross-sectional study<ref name="Mensah, 2016" />  [https://onlinelibrary.wiley.com/doi/full/10.1111/cei.12749 (Full Text)]
* 2018, [[CD24]] Expression and [[B cell|B Cell]] Maturation Shows a Novel Link With [[Metabolic|Energy Metabolism]]: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|title=CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full|journal=Frontiers in Immunology|date=2018|issn=1664-3224|volume=9|doi=10.3389/fimmu.2018.02421|language=English|first=Fane F. K. | last=Mensah|first2=Christopher W. | last2=Armstrong|first3=Venkat|last3=Reddy|first4=Amolak S. | last4=Bansal | first5 = Saul | last5 = Berkovitz|first6=Maria J. | last6 = Leandro | first7 = Geraldine | last7 = Cambridge|pages=|via=|author-link=Fane Mensah |author-link2=Christopher Armstrong|author-link7=Geraldine Cambridge|author-link3=Venkat Reddy |author-link4=Amolak Bansal|author-link5=Saul Berkovitz |author-link6=Maria Leandro}}</ref> [https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full (Full Text)]
* 2018, [[CD24]] Expression and [[B cell|B Cell]] Maturation Shows a Novel Link With [[Metabolic|Energy Metabolism]]: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal | title = CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full|journal=Frontiers in Immunology | date = 2018 | issn=1664-3224|volume=9|doi=10.3389/fimmu.2018.02421|language=English|first = Fane F.K. | last = Mensah | first2 = Christopher W. | last2 = Armstrong | first3 = Venkat | last3 = Reddy | first4 = Amolak S. | last4 = Bansal | first5 = Saul | last5 = Berkovitz | first6 = Maria J. | last6 = Leandro | first7 = Geraldine | last7 = Cambridge|pages=|via= | author-link = Fane Mensah | authorlink2 = Christopher Armstrong | authorlink7 = Geraldine Cambridge | authorlink3 = Venkat Reddy | authorlink4 = Amolak Bansal | authorlink5 = Saul Berkovitz | authorlink6 = Maria Leandro}}</ref> [https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full (Full Text)]


== Online presence ==
== Online presence ==
Line 15: Line 15:
== References ==
== References ==
<references>
<references>
<ref name="Mensah, 2016">{{Citation | last   = Mensah | first1 = Fane   | authorlink1 = Fane Mensah | last2 = Bansal | first2 = Amolak | authorlink2 = Amolak Bansal | last3= Berkovitz | first3 = Saul | authorlink3 = Saul Berkovitz | last4= Sharma | first4 = Arti | authorlink4 = | last5 = Reddy | first5 = Venkat | authorlink5 = Venkat Reddy | last6 =Leandro | first6 = Maria  | authorlink6 = Maria Leandro | last7 =Cambridge | first7 = Geraldine | authorlink7 = Geraldine Cambridge | title = Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study | journal = Clinical and Experimental Immunology   | volume = 184   | issue = 2 | page = 237-247 | date = 2016 | pmid = | doi = 10.1111/cei.12749 }}</ref>
<ref name="Mensah, 2016">{{Citation | last = Mensah | first1 = Fane | authorlink1 = Fane Mensah | last2 = Bansal | first2 = Amolak | authorlink2 = Amolak Bansal | last3 = Berkovitz | first3 = Saul | authorlink3 = Saul Berkovitz | last4 = Sharma | first4 = Arti | authorlink4 = | last5 = Reddy | first5 = Venkat | authorlink5 = Venkat Reddy | last6 = Leandro | first6 = Maria  | authorlink6 = Maria Leandro | last7 = Cambridge | first7 = Geraldine | authorlink7 = Geraldine Cambridge | title = Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study | journal = Clinical and Experimental Immunology | volume = 184 | issue = 2 | page = 237-247 | date = 2016 | pmid = | doi = 10.1111/cei.12749 }}</ref>
</references>
</references>
[[Category:Researchers]]
[[Category:Researchers]]
[[Category:UK researchers]]
[[Category:UK researchers]]

Latest revision as of 12:17, October 29, 2023

Maria Leandro, MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, United Kingdom. Her research interests are in inflammatory arthritis, rheumatoid arthritis, B cell directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.[1]

Notable studies[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. [hhttps://www.uclh.nhs.uk/our-services/find-consultant/dr-maria-leandro "Dr Maria Leandro - UCL Hospitals"].
  2. Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749
  3. Mensah, Fane F.K.; Armstrong, Christopher W.; Reddy, Venkat; Bansal, Amolak S.; Berkovitz, Saul; Leandro, Maria J.; Cambridge, Geraldine (2018). "CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Immunology. 9. doi:10.3389/fimmu.2018.02421. ISSN 1664-3224.